On June 27, 2025, Zimmer Biomet Holdings, Inc. entered into a $1.5 billion five-year revolving credit agreement and a $1 billion 364-day revolving credit agreement with JPMorgan Chase, replacing previous credit facilities. This indicates a commitment to enhancing their financial capacity for general corporate purposes and includes strict covenants regarding debt ratios.